Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA.

Published: January 2011

The development and synthesis of potent p38α MAP kinase inhibitors containing a pyridazinone platform is described. Evolution of the p38α selective pyridopyridazin-6-one series from the p38α/β dual inhibitor 2H-quinolizin-2-one series will be discussed in full detail.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2010.10.128DOI Listing

Publication Analysis

Top Keywords

map kinase
8
kinase inhibitors
8
synthesis biological
4
biological activity
4
activity pyridopyridazin-6-one
4
pyridopyridazin-6-one p38
4
p38 map
4
inhibitors development
4
development synthesis
4
synthesis potent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!